These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 10352283)
1. Perforin is a major contributor to NK cell control of tumor metastasis. Smyth MJ; Thia KY; Cretney E; Kelly JM; Snook MB; Forbes CA; Scalzo AA J Immunol; 1999 Jun; 162(11):6658-62. PubMed ID: 10352283 [TBL] [Abstract][Full Text] [Related]
2. The role of LY49 NK cell subsets in the regulation of murine cytomegalovirus infections. Tay CH; Yu LY; Kumar V; Mason L; Ortaldo JR; Welsh RM J Immunol; 1999 Jan; 162(2):718-26. PubMed ID: 9916691 [TBL] [Abstract][Full Text] [Related]
3. Cutting edge: expression of functional CD94/NKG2A inhibitory receptors on fetal NK1.1+Ly-49- cells: a possible mechanism of tolerance during NK cell development. Sivakumar PV; Gunturi A; Salcedo M; Schatzle JD; Lai WC; Kurepa Z; Pitcher L; Seaman MS; Lemonnier FA; Bennett M; Forman J; Kumar V J Immunol; 1999 Jun; 162(12):6976-80. PubMed ID: 10358137 [TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of immune-mediated lysis of murine renal cancer: differential contributions of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells. Sayers TJ; Brooks AD; Lee JK; Fenton RG; Komschlies KL; Wigginton JM; Winkler-Pickett R; Wiltrout RH J Immunol; 1998 Oct; 161(8):3957-65. PubMed ID: 9780164 [TBL] [Abstract][Full Text] [Related]
5. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous tumor growth. Takeda K; Smyth MJ; Cretney E; Hayakawa Y; Yamaguchi N; Yagita H; Okumura K Cell Immunol; 2001 Dec; 214(2):194-200. PubMed ID: 12088418 [TBL] [Abstract][Full Text] [Related]
6. Perforin dependence of natural killer cell-mediated tumor control in vivo. van den Broek MF; Kägi D; Zinkernagel RM; Hengartner H Eur J Immunol; 1995 Dec; 25(12):3514-6. PubMed ID: 8566046 [TBL] [Abstract][Full Text] [Related]
8. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively. Hashimoto W; Osaki T; Okamura H; Robbins PD; Kurimoto M; Nagata S; Lotze MT; Tahara H J Immunol; 1999 Jul; 163(2):583-9. PubMed ID: 10395644 [TBL] [Abstract][Full Text] [Related]
9. In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL. Lee SH; Bar-Haim E; Machlenkin A; Goldberger O; Volovitz I; Vadai E; Tzehoval E; Eisenbach L Cancer Gene Ther; 2004 Mar; 11(3):237-48. PubMed ID: 14739939 [TBL] [Abstract][Full Text] [Related]
10. Tumor regression after adoptive transfer of effector T cells is independent of perforin or Fas ligand (APO-1L/CD95L). Winter H; Hu HM; Urba WJ; Fox BA J Immunol; 1999 Oct; 163(8):4462-72. PubMed ID: 10510388 [TBL] [Abstract][Full Text] [Related]
11. Granzymes are essential for natural killer cell-mediated and perf-facilitated tumor control. Pardo J; Balkow S; Anel A; Simon MM Eur J Immunol; 2002 Oct; 32(10):2881-7. PubMed ID: 12355441 [TBL] [Abstract][Full Text] [Related]
12. Perforin, Fas ligand, and tumor necrosis factor are the major cytotoxic molecules used by lymphokine-activated killer cells. Lee RK; Spielman J; Zhao DY; Olsen KJ; Podack ER J Immunol; 1996 Sep; 157(5):1919-25. PubMed ID: 8757310 [TBL] [Abstract][Full Text] [Related]
13. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways. Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307 [TBL] [Abstract][Full Text] [Related]
14. Innate immune surveillance of spontaneous B cell lymphomas by natural killer cells and gammadelta T cells. Street SE; Hayakawa Y; Zhan Y; Lew AM; MacGregor D; Jamieson AM; Diefenbach A; Yagita H; Godfrey DI; Smyth MJ J Exp Med; 2004 Mar; 199(6):879-84. PubMed ID: 15007091 [TBL] [Abstract][Full Text] [Related]
15. Interferon-gamma-dependent phagocytic cells are a critical component of innate immunity against metastatic mammary carcinoma. Pulaski BA; Smyth MJ; Ostrand-Rosenberg S Cancer Res; 2002 Aug; 62(15):4406-12. PubMed ID: 12154047 [TBL] [Abstract][Full Text] [Related]
16. Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection. Kelly JM; Darcy PK; Markby JL; Godfrey DI; Takeda K; Yagita H; Smyth MJ Nat Immunol; 2002 Jan; 3(1):83-90. PubMed ID: 11743585 [TBL] [Abstract][Full Text] [Related]
17. Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cells. Andrews KJ; Ribas A; Butterfield LH; Vollmer CM; Eilber FC; Dissette VB; Nelson SD; Shintaku P; Mekhoubad S; Nakayama T; Taniguchi M; Glaspy JA; McBride WH; Economou JS Cancer Res; 2000 Nov; 60(22):6457-64. PubMed ID: 11103813 [TBL] [Abstract][Full Text] [Related]
18. Liver NK cells expressing TRAIL are toxic against self hepatocytes in mice. Ochi M; Ohdan H; Mitsuta H; Onoe T; Tokita D; Hara H; Ishiyama K; Zhou W; Tanaka Y; Asahara T Hepatology; 2004 May; 39(5):1321-31. PubMed ID: 15122761 [TBL] [Abstract][Full Text] [Related]
19. Differential requirement of perforin and IFN-gamma in CD8 T cell-mediated immune responses against B16.F10 melanoma cells expressing a viral antigen. Prévost-Blondel A; Neuenhahn M; Rawiel M; Pircher H Eur J Immunol; 2000 Sep; 30(9):2507-15. PubMed ID: 11009083 [TBL] [Abstract][Full Text] [Related]
20. Impact of FASL-induced apoptosis in the elimination of tumor cells by NK cells. Screpanti V; Wallin RP; Grandien A; Ljunggren HG Mol Immunol; 2005 Feb; 42(4):495-9. PubMed ID: 15607805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]